Ten Takeaways From FDA's 2013 Warning and Untitled Letters

The staff at Regulatory Focus read the FDA’s warning and untitled letters in order to glean some insight into where the agency may be focusing its efforts in the near future. They have put together a list of 10 best lessons to learn from the letters released by the FDA so far this year.
Regulatory Focus